CLINICAL CHARACTERISTICS AND QUALITY OF LIFE OF THAI MODERATE TO SEVERE PSORIASIS PATIENTS BEFORE INITIATING SECUKINUMAB: AN INTERIM ANALYSIS FROM PROMPT STUDY

被引：0
|
作者：
Wongpraparut, C. [1 ]
Tovanabutra, N. [2 ]
Laodheerasiri, S. [3 ]
Chakkavittumrong, P. [4 ]
Choonhakarn, C. [5 ]
Pattamadilok, B. [6 ]
Rattanakaemakorn, P. [7 ]
Sangob, N. [8 ]
Pongmesa, T. [9 ]
Asawanonda, P. [10 ]
机构：
[1] Siriraj Hosp, Bangkok, Thailand
[2] Chiang Mai Univ, Chiang Mai, Thailand
[3] Phramongkutklao Hosp, Bangkok, Thailand
[4] Thammasat Univ, Khlongluang, Pathum Tani, Thailand
[5] Khon Kaen Univ, Khon Kaen, Thailand
[6] Inst Dermatol, Bangkok, Thailand
[7] Ramathibodi Hosp, Bangkok, Thailand
[8] Novartis, Bangyai 12, Thailand
[9] Novartis, Bangkok, Thailand
[10] Chulalongkorn Univ, Bangkok, Thailand
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO112
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [21] Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study
    Costanzo, Antonio
    Russo, Filomena
    Galluzzo, Marco
    Stingeni, Luca
    Scuderi, Roberta
    Zichichi, Leonardo
    Papini, Manuela
    Di Costanzo, Luisa
    Conti, Andrea
    Burlando, Martina
    Chiricozzi, Andrea
    Gaiani, Francesca Maria
    Mugheddu, Cristina
    Musumeci, Maria Letizia
    Gisondi, Paolo
    Piaserico, Stefano
    Dapavo, Paolo
    Venturini, Marina
    Pagnanelli, Gianluca
    Amerio, Paolo
    Potenza, Concetta
    Peris, Ketty
    Cantoresi, Franca
    Trevisini, Sara
    Loconsole, Francesco
    Offidani, Annamaria
    Mercuri, Santo Raffaele
    Lora, Viviana
    Prignano, Francesca
    Bartezaghi, Marta
    Oliva, Giovanni
    Aloisi, Elisabetta
    Orsenigo, Roberto
    ACTA DERMATO-VENEREOLOGICA, 2021, 101
  • [22] Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study
    Koerber, A.
    Thaci, D.
    von Kiedrowski, R.
    Bachhuber, T.
    Melzer, N.
    Kasparek, T.
    Kraehn-Senftleben, G.
    Amon, U.
    Augustin, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 411 - 419
  • [23] Assessment of duration of transition from prior treatments to secukinumab treatment in moderate to severe psoriasis: Baseline characteristics from the PROSPECT study
    Thaci, Diamant
    von Kiedrowski, Ralph
    Koerber, Andreas
    Bachhuber, Teresa
    Melzer, Nima
    Kraehn-Senftleben, Gertraud
    Augustin, Matthias
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB49 - AB49
  • [24] Real-world experience of secukinumab in moderate to severe psoriasis patients in Thailand: Characteristics, effectiveness, and safety
    Asawanonda, Pravit
    Pattamadilok, Bensachee
    Chularojanamontri, Leena
    Chuamanochan, Mati
    Choonhakarn, Charoen
    Chakkavittumrong, Panlop
    Sangob, Naruemon
    Rajatanavin, Natta
    DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [25] Secukinumab demonstrated sustained retention and safety in a real-world setting in patients with moderate to severe plaque psoriasis: Long-term results from an interim analysis of the SERENA study
    Augustin, Matthias
    von Kiedrowski, Ralph
    Rigopoulos, Dimitris
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB107 - AB107
  • [26] INTERIM ANALYSIS OF BASELINE CHARACTERISTICS AND 12-WEEK OUTCOMES FOR A SUBSET OF PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND PSORIATIC ARTHRITIS FROM THE PSORIASIS STUDY OF HEALTH OUTCOMES
    Kristensen, L. E.
    Behrens, F.
    Puig, L.
    Reich, A.
    Holzkaemper, T.
    Brnabic, A.
    Ng, K.
    Leage, S. Liu
    Schuster, C.
    Pinter, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1562 - 1562
  • [27] Effectiveness and safety of secukinumab in 69 patients with moderate to severe plaque psoriasis: A retrospective multicenter study
    Schwensen, J. F.
    Clemmensen, A.
    Sand, C.
    Gniadecki, R.
    Skov, L.
    Zachariae, C.
    Iversen, L.
    Rasmussen, M.
    Thomsen, S. F.
    DERMATOLOGIC THERAPY, 2017, 30 (06)
  • [28] Effectiveness and security of secukinumab in patients with moderate to severe psoriasis in real clinical practice in a tertiary referral hospital
    Arteaga-Henriquez, Maria
    Lukoviek-Araya, Vania
    Maria Ramirez-Conchas, Jose
    Markthaler, Marcella
    Perez-Robayna, Nuria
    de-Andres-del-Rosario, Ana
    Guimera-Martin-Neda, Francisco
    Garcia-Bustinduy, Marta
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB51 - AB51
  • [29] The Impact of Tofacitinib on Quality of Life in Patients with Moderate-to-Severe Psoriasis- An Observational Study
    Mohta, Alpana
    Nyati, Asha
    Ghiya, Bhikam Chand
    Mehta, Rajesh Dutt
    Jain, Suresh Kumar
    INDIAN JOURNAL OF DERMATOLOGY, 2023, 68 (03) : 354
  • [30] Secukinumab treated patients in the Australian clinical practice setting: HOPE study investigating the quality of life in patients with severe chronic plaque psoriasis after treatment
    Foley, P.
    Walsh, M.
    Mate, E.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 39 - 39
12345